BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 7779130)

  • 1. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current options for the treatment of Paget's disease of the bone.
    Merlotti D; Gennari L; Martini G; Nuti R
    Open Access Rheumatol; 2009; 1():107-120. PubMed ID: 27789985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.
    Shaker JL
    Ther Adv Musculoskelet Dis; 2009 Apr; 1(2):107-25. PubMed ID: 22870432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with Paget's disease: a consensus document of the Belgian Bone Club.
    Devogelaer JP; Bergmann P; Body JJ; Boutsen Y; Goemaere S; Kaufman JM; Reginster JY; Rozenberg S; Boonen S;
    Osteoporos Int; 2008 Aug; 19(8):1109-17. PubMed ID: 18504638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM; Scott LJ
    Drugs; 2007; 67(5):793-804. PubMed ID: 17385948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of Paget's disease].
    Kurth AA
    Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for diagnosis and management of Paget's disease of bone in Japan.
    Takata S; Hashimoto J; Nakatsuka K; Yoshimura N; Yoh K; Ohno I; Yabe H; Abe S; Fukunaga M; Terada M; Zamma M; Ralston SH; Morii H; Yoshikawa H
    J Bone Miner Metab; 2006; 24(5):359-67. PubMed ID: 16937267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with Paget's disease of bone.
    Roux C; Dougados M
    Drugs; 1999 Nov; 58(5):823-30. PubMed ID: 10595863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New bisphosphonates in the treatment of bone diseases.
    Gatti D; Adami S
    Drugs Aging; 1999 Oct; 15(4):285-96. PubMed ID: 10582775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic evaluation of tiludronic acid treatment in Paget's disease of bone.
    Lafuma A; Fagnani F; Meunier PJ
    Pharmacoeconomics; 1997 Oct; 12(4):460-74. PubMed ID: 10174312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in bone diseases.
    Sparidans RW; Twiss IM; Talbot S
    Pharm World Sci; 1998 Oct; 20(5):206-13. PubMed ID: 9820883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone.
    Fraser WD; Stamp TC; Creek RA; Sawyer JP; Picot C
    Postgrad Med J; 1997 Aug; 73(862):496-502. PubMed ID: 9307742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paget's disease of bone: diagnosis and management.
    Hosking D; Meunier PJ; Ringe JD; Reginster JY; Gennari C
    BMJ; 1996 Feb; 312(7029):491-4. PubMed ID: 8597686
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
    Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
    Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
    Reginster JY; Colson F; Morlock G; Combe B; Ethgen D; Geusens P
    Arthritis Rheum; 1992 Aug; 35(8):967-74. PubMed ID: 1642662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The methodology of clinical trials of oral tiludronate in Paget's disease of bone.
    Roux C
    Bone; 1995 Nov; 17(5 Suppl):497S-499S. PubMed ID: 8573426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone.
    Devogelaer JP; Malghem J; Stasse P; Nagant de Deuxchaisnes C
    Bone; 1997 Mar; 20(3):259-61. PubMed ID: 9071477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.
    Drake WM; Kendler DL; Brown JP
    Clin Ther; 2001 Apr; 23(4):620-6. PubMed ID: 11354395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiludronate. A new treatment for an old ailment: Paget's disease of bone.
    Morales-Piga A
    Expert Opin Pharmacother; 1999 Nov; 1(1):157-70. PubMed ID: 11249559
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.